Neuropsychopharmacology: A Tribute to Joseph T. Coyle

Preface<br>Robert Schwarcz and S.J. Enna<br>Foreword<br>Solomon H. Snyder<br>1. My Life in Clinical Neuroscience: The Beginning <br>Joseph T Coyle<br>2. Kynurenines and Glutamate: Multiple Links and Therapeutic Implications<br>Robert Schwarcz<br>3. The Therapeutic Role of D-Cycloserine in Schizophrenia<br>Donald Goff<br>4. Impulsivity, Stimulant Abuse and Dopamine Receptor Signaling<br>Edythe D. London<br>5. Excitotoxicity as a Common Mechanism for Fetal Neuronal Injury with Hypoxia and Intrauterine Inflammation<br>Irina Burd, Jared Welling, Gokul Kannan, Michael V. Johnston<br>6. Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors<br>Zila Martinez-Lozada, Alain M. Guillem and Michael B. Robinson<br>7. The Long and Winding Road: From the High Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors<br>Pedro R. Lowenstein and Maria G. Castro<br>8. Choline on the Move: Perspectives on the Molecular Physiology and Pharmacology of the Presynaptic Choline Transporter<br>Elizabeth A. Ennis and Randy D. Blakely<br>9. Still NAAG’ing after all these Years: The Continuing Pursuit of GCPII Inhibitors<br>James J. Vornov, Kristen R. Hollinger, Paul F. Jackson, Krystyna M. Wozniak, Mohamed H. Farah, Pavel Majer, Rana Rais and Barbara S. Slusher<br>10.  Ultimate Translation; Developing Therapeutics Targeting on N-methyl-D-aspartate Receptor<br>Guochuan Emil Tsai<br>11.  The Good and Bad Sides of NAAG<br>Pamela Khacho, Boyang Wang and Richard Bergeron<br>12.  The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment<br>Darrick T. Balu